Skip to content

Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism

Effect of Hyperbaric Therapy on Markers of Oxidative Stress in Children With Autism: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00263367
Enrollment
10
Registered
2005-12-08
Start date
2005-10-31
Completion date
2006-02-28
Last updated
2011-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism, Oxidative Stress

Keywords

Autism, Oxidative Stress, Hyperbaric Oxygen, Reduced Glutathione, Lipid Peroxides

Brief summary

This study will look at the changes taking place in the blood levels of key markers of oxidative stress. Oxidative stress is the biological equivalent of rust on a car. It changes vital cell chemistry. It is known to occur at high pressure oxygen, but little is known about changes at pressures slightly greater than normal atmospheric pressure. Hyperbaric therapy is used in a variety of medical conditions. It is being tested in this study only for safety. It is not being assessed for the ability of hyperbaric oxygen to improve the clinical condition of children with autism. This study was felt to be important since autism appears to be associated with oxidative stress and hyperbarics was being used off-label for this condition without safety studies.

Detailed description

Blood will be drawn immediately prior to a one hour session of hyperbarics (HBT. A catheter will be inserted in to a vein and converted to a heparin lock indwelling port for the next blood draw. The child (ages 5-12 years) will then undergo 1 hour of compression at 1.3 atmospheric pressure (4 psi above room air pressure). Supplemental oxygen will be provided to the child. A second blood draw from the catheter site will be accomplished immediately after the child comes out of the HBT chamber. These will be sent to the laboratories for evaluation of changes in reduced glutathione and lipid peroxides.

Interventions

OTHERHyperbaric Oxygen

Hyperbaric Oxygen at 1.3 ATA for one hour

Sponsors

The International Child Development Resource Center
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
5 Years to 12 Years
Healthy volunteers
No

Inclusion criteria

* Children diagnosed with autism ages 5-12 and undergoing hyperbarics

Exclusion criteria

* Seizures, acute URI, or inability to ventilate ears

Design outcomes

Primary

MeasureTime frameDescription
glutathione1 hourmeasurement of glutathione immediately after one hour of exposure to low dose HBOT

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026